CVNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
CapsoVision, Inc
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$6.67+0.14 (+2.14%)
Close on Oct 19, 2026
- Market cap
- $333.08M
- P/E (TTM)
- –
- Dividend yield
- –
Fundamental chart
Pick a measure to chart its full history
$13.55MFY2025, +15.3% a year since FY2024